Geoclock® Technology_Customisable chronotherapy

Geoclock® Technology_Customisable chronotherapy
Product Description

Geoclock® allows for timed release of drugs that is independent of food or pH. Geoclock® is a validated oral drug delivery technology that can be used to release the drug from the tablet after a pre-determined lag-time that is independent of food or pH. Geoclock® can additionally be used for multiple pulse delivery of one or more drugs with pre-determined time intervals between the pulses, or to target colonic release of drugs. Where more than one drug is included, the delivery profile can be different for each active pharmaceutical ingredient. Geoclock® is easily manufactured using conventional production equipment, minimising the need for capital investment.
This technology is already on the market, manufactured by Skyepharma for Horizon: Lodotra® and Rayos®.

SKYEPHARMA PRODUCTION S.A.S

  • FR
  • 2017
    On CPhI since

SKYEPHARMA PRODUCTION S.A.S

  • FR
  • 2017
    On CPhI since

More Products from SKYEPHARMA PRODUCTION S.A.S

  • Early stage formulation Development & Process Design

    Product Early stage formulation Development & Process Design

    We have extensive experience in solving complex formulation challenges. Our experts can apply our extensive range of proprietary technologies for immediate (IR) and modified (MR) / sustained, slow (SR) / controlled (CR) / extended (XR, ER) / pulsed / timed release as well as enteric and gastro retentive release in order to solve technological challenges, to provide patient benefits and to offer additional proprietary protection to the product.

    We have expertise iwth different types of molecules:
    - New chemical entity (NCE)
    - Small molecules
    - Proteins
  • Clinical trial material (CTM) manufacturing and release

    Product Clinical trial material (CTM) manufacturing and release

    We offer capabilities for manufacturing of small and large scale clinical trial material (CTM) as well as characterization and release from phase 1 to phase 3.
  • Manufacturing of complex and classic oral solid dosage forms

    Product Manufacturing of complex and classic oral solid dosage forms

    Manufacturing of classic and complex oral solid dosage forms:  single layer tablets, multi-layer tablets, tab-in-tab, tab-in-caps, hard gel capsules, powder & pellets.
  • Analytical Development and expertise

    Product Analytical Development and expertise

    Our analytical experienced team support the pharmaceutical development during every phase of the development process. Analytical development transfer and validation, characterization capabilities, stability analysis, ICH Q3D (residuals solvent risk assesment), ICHQ3C (elemental impurities risk assesment) and Extractable Leachable (EL) capabilities.
    Equipment:
    Centrifugation for heat-sensitive productsSurface area and pore size analyzer (BET)Friability, disintegration, viscometry, etc.Brookfield viscometerUV-Visible and IR/NIR spectrophotometers (Perkin Elmer)Karl Fisher titrator (Mettler)PotentiometryLaser diffraction particle size analysis (Malvern)Total organic carbon (TOC) analyzerHPLC/UHPLC (water/agilent) with PDA multiwavelength detector, UV detector, refractometerGas chromatography (GC) detectors: FID & TCDUV On-/Offline automated dissolution testing (SOTAX)Automatic Mortar Grinder, Stability cambers, Vitek®, BET Surface Area and Pore Size Analyzer.
  • Scale-up and Quality by Design (QbD) processes

    Product Scale-up and Quality by Design (QbD) processes

    Skyepharma is experienced with the scale-up of complex oral solid dosage forms from laboratory to pilot-scale and full commercial scale manufacturing. We have powerfull compaction simulation tools ( STYL'One evolution) allowing to derisk and fasten scale-up steps. 
    Our capabilities : Wet granulation, Drying, Milling, Lubrication & blending, Tableting, Film coating, capsule filing, Roller compactor, Microfluidizer and packaging.
    Our Quality by Design (QbD) strategy comprises :- Failure Mode and Effect Analysis (FMEA)
    - Fault Tree Analysis (FTA)
    - Design of Experiment (DOE)
    - Design space determination. 
  • Packaging in Blister

    Product Packaging in Blister

    Primary packaging: Forming station for both PVCs and aluminium and all kind of feeder for tablets and capsules. Secondary packaging: Labelling, carton and casepacker.
  • Packaging in Bottle

    Product Packaging in Bottle

    Primary packaging : Plastic and glass bottles (round and square) loading station. Secondary packaging : sealing, labelling, carton and casepacker.
  • Packaging in Stick Pack

    Product Packaging in Stick Pack

    We can offer batch sizes from a few kilograms to several hundreds and the equipment is versatile in terms of material: powder, granules or pellets can be filled with PET / ALU / PE complex films up to 17 mm wide and up to 150 mm long. 
  • Serialization and Aggregation

    Product Serialization and Aggregation

    Bottle and blister lines fully serialized and aggregate.
  • Geomatrix® Technology_Customisable drug delivery platform

    Product Geomatrix® Technology_Customisable drug delivery platform

    Geomatrix® provides a customisable drug delivery platform for controlled release versions of orally available molecules. The combination of layers, each with different rates of swelling, gelling and erosion, controls the drug release rate within the body Geomatrix® is is currently used in 8 products that are available in over 80 countries. Geomatrix® is highly versatile and can be applied to a wide range of different drugs to achieve a variety of different release profiles. It uses well-established ingredients and is easily manufactured using conventional production equipment.
    This technology is already on the market, manufactured by Skyepharma for these clients and products   Sanofi: Xatral® and Uroxatral®, GSK: Paxil CR™ and Requip®, Therabel: Coruno®, Teva: Diclofenac-ratiopharm®, Chiesi US: uno-zyflo CR®, Roche: Madopar DR®, Covis: Sular®.

  • Soctec® Technology_Self Orienting Capsule Technology

    Product Soctec® Technology_Self Orienting Capsule Technology

    Soctec® was developed for drugs that need to be retained in the stomach for an extended period of time to then being slowly released either for a local effect in the stomach or for absorption in the upper intestine. Soctec® is a versatile extended release gastro-retentive platform technology that has been designed to overcome many of the limitations of alternative systems. Skyepharma’s Soctec® is  designed to retain a drug in the stomach for an extended period of time so that it can be delivered in a controlled way to the duodenum and jejunum for subsequent absorption, so improving oral bioavailability and duration of action for sustained release formulations.
    This technology is under in vivo proof of concept.
  • Medicated chewing gum technology

    Product Medicated chewing gum technology

    Our proprietary medicated chewing gum technology uses an approach similar to multilayer tableting. A combination of layers modulates the release rate of the active ingredients and flavouring agents when the gum is chewed.

SKYEPHARMA PRODUCTION S.A.S resources

Recommended products